ArticlePloS one2026
BioFuse: an embedding fusion framework for biomedical foundation models.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The biomedical field has witnessed a surge in pre-trained foundation models excelling in specific subdomains such as radiology and histopathology. While integrating these models promises a more comprehensive understanding of biomedical data, it poses challenges in model compatibility and feature fusion. We present BioFuse, a novel open-source framework designed to generate optimised biomedical embeddings. BioFuse utilises a pool of 9 state-of-the-art (SOTA) foundation models to create task-specific embeddings. It employs grid search to automatically identify the optimal combination of models, fusing their embeddings through vector concatenation. On the MedMNIST+ benchmark, using XGBoost as the downstream classifier, BioFuse outperforms several existing methods, achieving SOTA AUC in 5/12 datasets, while maintaining near-SOTA performance across most remaining datasets. Remarkably, our experiments reveal unexpected cross-modal capabilities, with histopathology and radiology models showing strong performance when applied to other imaging modalities. BioFuse features a high-level API for immediate deployment and an extensible architecture to incorporate future models and fusion techniques. We anticipate BioFuse will not only enhance the utility of foundation models in biomedicine but also open new avenues for uncovering cross-modal relationships in biomedical data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.